Moleculin Biotech Inc.
09/30/2025 | Press release | Distributed by Public on 10/01/2025 04:07
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 30, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
|
|||||||
Moleculin Biotech Inc. published this content on September 30, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 01, 2025 at 10:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]